Belgium· BE-AMP-SAM157394-00

Myk-1 10 mg/ml

A sulconazole product containing sulconazole nitrate, registered in Belgium by Will Pharma. The same ATC class is registered in 5 of our 19 countries.

ATC D01AC09

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedMyk-1 10 mg/mlATCD01AC09REGISTER NO.BE-AMP-SAM157394-00PACKS LISTED1CHECKEDSeptember 26, 2026

Where it is registered

Sulconazole is registered in 5 of 19 countries.

Countries holding a registration under ATC D01AC09 (sulconazole), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 2 of them publish a price we can compare per daily dose

Sulconazole · ATC D01AC09

5 / 19 countries

  • Belgiumprice
  • Japan
  • Netherlands
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Sulconazole Nitrate
Manufacturer
Will Pharma
Country
Belgium (BE)
ATC code
D01AC09
ATC class
Sulconazole
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    0391490

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Sulconazole in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sulconazole products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Luxembourg · Myk-1
  • Netherlands · Myk-1

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/eeae7b39-11e9-453c-8ece-1dad5d512ade
GET /v1/drugs/eeae7b39-11e9-453c-8ece-1dad5d512ade?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Cutaneous solution",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Myk-1 10 mg/ml",
  "name_fr": "Myk-1 10 mg/ml",
  "name_nl": "Myk-1 10 mg/ml",
  "amp_code": "SAM157394-00",
  "strengths": [
    "10.0000",
    "0.1000",
    "350.0000",
    "0.4000",
    "40.0000"
  ],
  "pack_count": 2,
  "substances": [
    "Sulconazole Nitrate",
    "Butylhydroxyanisole",
    "Propylene Glycol",
    "Sodium Hydroxide",
    "Polysorbate 20"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Sulconazole",
  "authorisation_numbers": [
    "BE157394"
  ]
}

See everything about sulconazole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.